Company / Assets per Share
Nuvation Bio Inc. Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$1.76
FY2025
5-year range
$1.76 / $3922.19
FY2021-FY2025
Trend
-28.7%
vs FY2024
Sector context
#192 of 210
Health Care
What the data says
Among 210 Health Care companies, Nuvation Bio Inc. is in the bottom 9% for assets per share. Assets per Share has declined for 4 consecutive years, from $3922.19 in FY2021 to $1.76 in FY2025.
Based on SEC 10-K filings.
1.76 in FY2025 with a 5-year CAGR of -5.0%.
Declined from $2839.38 to $1.76 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -91.7%
- 5-Year CAGR
- -5.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 210This company $1.76 Sector average $353.16
▼
-99.5% below sector average
Key checks
Key Insights
- Nuvation Bio Inc.'s assets per share has declined for 4 consecutive years.
- In FY2025, assets per share decreased 28.7% year-over-year.
- Ranks #192 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.76 | -28.7% |
| FY2024 | $2.47 | -99.9% |
| FY2023 | $2839.38 | -8.4% |
| FY2022 | $3101.41 | -20.9% |
| FY2021 | $3922.19 | +172373.1% |
| FY2020 | $2.27 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026